Importance of specimen length during temporal artery biopsy

British Journal of Surgery

Volumn 98, Issue 11, 2011, Pages 1556-1560

  Ypsilantis, E ^a,b   Courtney, E D ^a,f   Chopra, N ^b,c   Karthikesalingam, A ^e   Eltayab, M ^f   Katsoulas, N ^d   Tang, T Y ^e,f   Ball, R Y ^f  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b East Sussex Healthcare NHS Trust   (United Kingdom)

^c EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^d WEST SUFFOLK HOSPITAL   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; FEMALE; GIANT CELL ARTERITIS; HUMAN; LABORATORY DIAGNOSIS; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TEMPORAL ARTERY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; SPECIMEN HANDLING; TEMPORAL ARTERIES; YOUNG ADULT;

EID: 80053566548     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7595     Document Type: Article

References (29)

1. Chew SS, Kerr NM, Danesh-Meyer HV,. Giant cell arteritis. J Clin Neurosci 2009; 16: 1263-1268.
2. Bengtsson BA, Malmvall BE,. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 1981; 24: 899-904. (Pubitemid 11070091)
3. Weyand CM, Goronzy JJ,. Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med 2002; 69 (Suppl 2): SII28-SII32. (Pubitemid 41315550)
4. Foss F, Brown L,. An elastic Van Gieson stain is unnecessary for the histological diagnosis of giant cell temporal arteritis. J Clin Pathol 2010; 63: 1077-1079.
5. Kale N, Eggenberger E,. Diagnosis and management of giant cell arteritis: a review. Curr Opin Ophthalmol 2010; 21: 417-422.
6. Kyle V,. Treatment of polymyalgia rheumatica/giant cell arteritis. Baillieres Clin Rheumatol 1991; 5: 485-491.
7. Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B, et al.,; BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010; 49: 1594-1597.
8. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128. (Pubitemid 20273297)
9. Ball EL, Walsh SR, Tang TY, Gohil R, Clarke JM,. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010; 97: 1765-1771.
10. Lee AG, Brazis PW,. Temporal arteritis: a clinical approach. J Am Geriatr Soc 1999; 47: 1364-1370. (Pubitemid 29523212)
11. Klein RG, Campbell RJ, Hunder GG, Carney JA,. Skip lesions in temporal arteritis. Mayo Clin Proc 1976; 51: 504-510.
12. Mahr A, Saba M, Kambouchner M, Polivka M, Baudrimont M, Brochériou I, et al., Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis 2006; 65: 826-828. (Pubitemid 43799187)
13. Gordon LK, Levin LA,. Visual loss in giant cell arteritis. JAMA 1998; 280: 385-386. (Pubitemid 28503227)
14. Taylor-Gjevre R, Vo M, Shukla D, Resch L,. Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005; 32: 1279-1282. (Pubitemid 40995383)
15. Arashvand K,. The value of temporal artery biopsy specimen length in the diagnosis of giant cell arteritis. J Rheumatol 2006; 33: 2363-2364. (Pubitemid 44749807)
16. Tomsak RL,. Superficial temporal artery biopsy. A simplified technique. J Clin Neuroophthalmol 1991; 11: 202-204.
17. Gilmour D, Sykes AJ,. Westergren and Wintrobe methods of estimating ESR compared. Br Med J 1951; 2: 1496-1497.
18. Walvick MD, Walvick MP,. Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology 2011; [Epub ahead of print].
19. Zhou L, Luneau K, Weyand CM, Biousse V, Newman NJ, Grossniklaus HE,. Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. Ophthalmology 2009; 116: 1574-1580.
20. Schmidt WA,. Doppler ultrasonography in the diagnosis of giant cell arteritis. Clin Exp Rheumatol 2000; 18 (Suppl 20): S40-S42. (Pubitemid 30655854)
21. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE,. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994; 120: 987-992. (Pubitemid 24169277)
22. Caroe A,. Temporal artery biopsy to diagnose temporal arteritis. JAMA 1998; 280: 1992. (Pubitemid 28562673)
23. Su GW, Foroozan R, Yen MT,. Quantitative analysis of temporal artery contraction after biopsy for evaluation of giant cell arteritis. Can J Ophthalmol 2006; 41: 500-503. (Pubitemid 44298967)
24. Weinberg DA, Savino PJ, Sergott RC, Bosley TM,. Giant cell arteritis. Corticosteroids, temporal artery biopsy, and blindness. Arch Fam Med 1994; 3: 623-627.
25. Niederkohr RD, Levin LA,. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci 2007; 48: 675-680. (Pubitemid 351260700)
26. Breuer GS, Nesher R, Nesher G,. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol 2009; 27 (Suppl 52): S10-S13.
27. Sharma NS, Ooi JL, McGarity BH, Vollmer-Conna U, McCluskey P,. The length of superficial temporal artery biopsies. ANZ J Surg 2007; 77: 437-439. (Pubitemid 46733803)
28. Sudlow C,. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy. BMJ 1997; 315: 549.
29. Kent RB III, Thomas L,. Temporal artery biopsy. Am Surg 1990; 56: 16-21. (Pubitemid 20132039)